BPA
TRAW icon

Beacon Pointe Advisors’s Traws Pharma TRAW Stock Holding History

Beacon Pointe Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-509
Closed -$5.68K – 1326
2024
Q2 		$5.68K Sell
509
-42
-8% -$677 ﹤0.01% 1264
2024
Q1 		$13.9K Sell
551
-589
-52% -$11.4K ﹤0.01% 1350
2023
Q4 		$21.3K Buy
1,140
+3
+0.3% +$51 ﹤0.01% 1308
2023
Q3 		$20.2K Hold
1,137
– – ﹤0.01% 1321
2023
Q2 		$33.5K Buy
1,137
+612
+117% +$16.5K ﹤0.01% 1069
2023
Q1 		$9.59K Sell
525
-1,049
-67% -$22.7K ﹤0.01% 1136
2022
Q4 		$25.4K Sell
1,574
-384
-20% -$7.24K ﹤0.01% 1049
2022
Q3 		$42K Sell
1,958
-121
-6% -$3.66K ﹤0.01% 982
2022
Q2 		$68K Buy
2,079
+238
+13% +$8.03K ﹤0.01% 1016
2022
Q1 		$85K Buy
1,841
+1,096
+147% +$50.8K ﹤0.01% 1164
2021
Q4 		$48K Sell
745
-313
-30% -$25.2K ﹤0.01% 913
2021
Q3 		$101K Buy
1,058
+99
+10% +$12.8K ﹤0.01% 879
2021
Q2 		$166K Buy
959
+260
+37% +$58.8K 0.01% 803
2021
Q1 		$260K Sell
699
-103
-13% -$38.9K 0.02% 421
2020
Q4 		$136K Sell
802
-107
-12% -$12.4K 0.01% 492
2020
Q3 		$95K Buy
909
+274
+43% +$67.7K 0.01% 390
2020
Q2 		$131K Buy
+635
New +$97K 0.01% 388

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VWWMG
Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Beacon Pointe Advisors's TRAW Position: Q3 2024 in Review

Beacon Pointe Advisors sold out of Traws Pharma (TRAW) in Q3 2024, closing a stake of 509 shares — an estimated $5.68K sold.

Beacon Pointe Advisors first reported a position in TRAW in Q2 2020 and held it in 17 quarters. The position peaked at $260K in Q1 2021. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2024.

  • Beacon Pointe Advisors reported no remaining Traws Pharma position as of Q3 2024 after selling out during the quarter.
  • Beacon Pointe Advisors sold 509 Traws Pharma shares in Q3 2024, an estimated $5.68K.
  • Beacon Pointe Advisors first reported a position in Traws Pharma in Q2 2020 and held it in 17 quarters.
  • Beacon Pointe Advisors's Traws Pharma position peaked at $260K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2024.

Based on Beacon Pointe Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.